Astex Pharmaceuticals has selected the Thermo Scientific Glacios Cryo Transmission Electron Microscope (Cryo-TEM) to aid in its drug discovery and development program. Astex’s research focuses on oncology and diseases of the central nervous system. They will install the Glacios Cryo-TEM at their research and development headquarters in Cambridge, UK. Astex is one of five pharmaceutical companies participating with Thermo…
Thermo Fisher Invests $50M To Enhance Biologics Capabilities
Thermo Fisher Scientific is investing $50 million in its St. Louis, MO, site, one of the company’s Centers of Excellence (COE) for Biological Commercial Manufacturing. The investment is part of a strategy to continue expansion of the company’s global network of biologic drug substance capabilities for clinical and commercial supply. The project includes expansion to the…
Thermo Fisher Scientific Signs New Agreements To Expand Oncomine Dx Target Test
Thermo Fisher Scientific announced today it has signed new agreements with Daiichi Sankyo and Takeda Pharmaceuticals designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs at each of the firms. The agreements will focus on validating additional biomarkers and gene variants on the test and support Thermo Fisher’s commitment…
Juno Therapeutics And Thermo Fisher Scientific Enter CAR T Manufacturing Partnership
Juno Therapeutics and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 magnetic beads as part of…
